Paper347289
Complete correction of the Wiskott-Aldrich syndrome by allogeneic bone-marrow transplantation.
Parkman R and 7 others. N Engl J Med, 1978. Cited by 161 papers, by iCite.
11 sourcespapers-2026-11-12-0.1.0
Cite this record
ConductScience Library. Complete correction of the Wiskott-Aldrich syndrome by allogeneic bone-marrow transplantation. Papers, record 347289. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/347289
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Title
- Complete correction of the Wiskott-Aldrich syndrome by allogeneic bone-marrow transplantation.
- PubMed
Topics16
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Bone Marrow Transplantation | Major topic |
| Wiskott-Aldrich Syndrome | Major topic |
| Antilymphocyte Serum | |
| Child | |
| Child, Preschool | |
| Cyclophosphamide | |
| Cytarabine | |
| Histocompatibility | |
| Humans | |
| Male | |
| Preoperative Care | |
| Procarbazine | |
| Radiation Effects | |
| T-Lymphocytes | |
| Time Factors | |
| Transplantation, Homologous |
Source PubMed
Cited by48
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 161 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 41,718,912 | A Cohort Study of 38 Classic Wiskott-Aldrich Syndrome Cases with Six Novel Mutations. | J Clin Immunol | 2026 | https://conductscience.org/library/papers/41718912 | PubMed |
| 40,209,058 | How I treat Wiskott-Aldrich syndrome. | Blood | 2025 | https://conductscience.org/library/papers/40209058 | PubMed |
| 39,846,592 | Advancing Newborn Screening in Washington State: A Novel Multiplexed LC-MS/MS Proteomic Assay for Wilson Disease and Inborn Errors of Immunity. | Int J Neonatal Screen | 2025 | https://conductscience.org/library/papers/39846592 | PubMed |
| 36,926,165 | Successful surgical repair of critical ascending and descending aortic aneurysms at nine-year intervals in Wiskott-Aldrich syndrome: A case report. | Turk Gogus Kalp Damar Cerrahisi Derg | 2023 | https://conductscience.org/library/papers/36926165 | PubMed |
| 36,059,471 | Genome editing for primary immunodeficiencies: A therapeutic perspective on Wiskott-Aldrich syndrome. | Front Immunol | 2022 | https://conductscience.org/library/papers/36059471 | PubMed |
| 33,633,315 | Wiskott Aldrich syndrome: healthcare utilizations and disparities in transplant care. | Sci Rep | 2021 | https://conductscience.org/library/papers/33633315 | PubMed |
| 33,102,615 | WAS Promoter-Driven Lentiviral Vectors Mimic Closely the Lopsided WASP Expression during Megakaryocytic Differentiation. | Mol Ther Methods Clin Dev | 2020 | https://conductscience.org/library/papers/33102615 | PubMed |
| 32,788,576 | Targeted gene correction of human hematopoietic stem cells for the treatment of Wiskott - Aldrich Syndrome. | Nat Commun | 2020 | https://conductscience.org/library/papers/32788576 | PubMed |
| 29,086,100 | Clinical Manifestations and Pathophysiological Mechanisms of the Wiskott-Aldrich Syndrome. | J Clin Immunol | 2018 | https://conductscience.org/library/papers/29086100 | PubMed |
| 28,270,364 | New frontiers in the therapy of primary immunodeficiency: From gene addition to gene editing. | J Allergy Clin Immunol | 2017 | https://conductscience.org/library/papers/28270364 | PubMed |
| 27,157,594 | To condition or not to condition-That is the question: The evolution of nonmyeloablative conditions for transplantation. | Exp Hematol | 2016 | https://conductscience.org/library/papers/27157594 | PubMed |
| 25,259,542 | Stem cell transplantation for primary immunodeficiency diseases: the North American experience. | Curr Opin Allergy Clin Immunol | 2014 | https://conductscience.org/library/papers/25259542 | PubMed |
| 22,553,502 | Hematopoietic stem cell transplantation in thalassemia and sickle cell anemia. | Cold Spring Harb Perspect Med | 2012 | https://conductscience.org/library/papers/22553502 | PubMed |
| 22,426,750 | Outcomes following hematopoietic cell transplantation for Wiskott-Aldrich syndrome. | Bone Marrow Transplant | 2012 | https://conductscience.org/library/papers/22426750 | PubMed |
| 21,415,995 | Hematopoietic stem cell transplantation in thalassemia and sickle cell disease. Unicenter experience in a multi-ethnic population. | Mediterr J Hematol Infect Dis | 2009 | https://conductscience.org/library/papers/21415995 | PubMed |
| 20,493,395 | Hematopoietic cell transplantation for Wiskott-Aldrich syndrome: advances in biology and future directions for treatment. | Immunol Allergy Clin North Am | 2010 | https://conductscience.org/library/papers/20493395 | PubMed |
| 20,071,242 | Update on gene therapy for immunodeficiencies. | Clin Immunol | 2010 | https://conductscience.org/library/papers/20071242 | PubMed |
| 18,084,339 | Unrelated cord blood transplantation for severe combined immunodeficiency and other primary immunodeficiencies. | Bone Marrow Transplant | 2008 | https://conductscience.org/library/papers/18084339 | PubMed |
| 17,013,426 | Stem cell transplantation for the Wiskott-Aldrich syndrome: a single-center experience confirms efficacy of matched unrelated donor transplantation. | Bone Marrow Transplant | 2006 | https://conductscience.org/library/papers/17013426 | PubMed |
| 15,549,305 | Allogeneic stem cell transplantation for the treatment of diseases associated with a deficiency in bone marrow products. | Springer Semin Immunopathol | 2004 | https://conductscience.org/library/papers/15549305 | PubMed |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- Comments and corrections
- References
- Genes
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/347289
GET https://conductscience.org/api/papers/v1/347289/cited_by?page=2